FDA Clearance Tracker · P960052
DERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)
Last checked: Nov 19, 2026Latest source record: Aug 26, 1998 (this decision)Source: openFDAMethods & limitations
Decided
Aug 26, 1998
Approved (reclassified)
Time to decision
610 days
Received Dec 24, 1996. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class II
The decision
- FDA number
- P960052
- Device name
- DERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)
- Applicant
- Closure Medical Corp.
- Applicant location
- Raleigh, NC
- Received
- Dec 24, 1996
- Decided
- Aug 26, 1998
- Decision
- Approved (reclassified)
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 11 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.4010
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
This device is indicated for topical application to hold closed easily approximated skin edges from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. DermaBond(TM) may be used in conjunction with, but not in place of, subcuticular sutures.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MPN (Tissue adhesive for the topical approximation of skin).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Closure Medical Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.